NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

If they really have had around 250 non-trial patients this year, they might actually have decent revenue to report

Vikinginvest,

Not possible, IMO.

The Company has been unable to undertake compassionate use cases during part of March and during Q2, due to lockdowns, travel restrictions and hospitals focusing most of their personnel and resources on COVID-19 patients. In addition, manufacturing of DCVax products is impeded by personnel being under lockdown, and the buildout of the Sawston facility was delayed in starting due to the construction sector shutdown and restrictions, and the duration of the work will be substantially longer due to the contractors having to operate under social distancing arrangements. The Company anticipates that such effects of the COVID-19 situation may continue for an extended period of time.

https://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=14323373-870-179660&type=sect&TabIndex=2&companyid=89350&ppu=%252fdefault.aspx%253fcik%253d1072379